bf/NYSE:CVS_icon.jpeg

COM:CVSHEALTH

CVS Health

  • Stock

Last Close

57.10

22/11 21:00

Market Cap

73.00B

Beta: -

Volume Today

10.45M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
10.90B
-
11.49B
5.37%
12.97B
12.87%
14.38B
10.91%
15.03B
4.50%
15.87B
5.62%
16.98B
6.99%
18.01B
6.02%
18.13B
0.68%
18.43B
1.64%
18.56B
0.72%
average payables
5.31B
-
6.05B
13.91%
7.02B
16.06%
7.72B
9.97%
8.40B
8.89%
8.89B
5.82%
9.71B
9.16%
10.81B
11.40%
11.84B
9.49%
13.69B
15.62%
14.87B
8.59%
average receivables
7.60B
-
9.21B
21.14%
10.79B
17.15%
12.03B
11.48%
12.67B
5.38%
15.41B
21.57%
18.62B
20.89%
20.68B
11.04%
23.09B
11.64%
25.85B
11.99%
31.25B
20.88%
book value per share
31.17
-
32.69
4.88%
33.27
1.76%
34.32
3.17%
36.95
7.66%
55.77
50.93%
49.09
11.98%
53.01
7.99%
56.92
7.37%
54.13
4.90%
59.50
9.93%
capex per share
-1.63
-
-1.84
12.85%
-2.12
15.08%
-2.07
2.10%
-1.88
9.28%
-1.95
3.76%
-1.89
3.21%
-1.86
1.42%
-1.91
2.62%
-2.08
8.79%
-2.36
13.48%
capex to depreciation
-1.06
-
-1.11
4.26%
-1.13
2.29%
-0.90
20.58%
-0.77
13.90%
-0.75
3.13%
-0.56
25.00%
-0.55
2.38%
-0.56
1.78%
-0.64
14.97%
capex to operating cash flow
-0.34
-
-0.26
23.48%
-0.28
7.19%
-0.22
21.50%
-0.24
8.45%
-0.23
4.07%
-0.19
16.77%
-0.15
19.68%
-0.14
10.18%
-0.17
22.18%
-0.23
33.92%
capex to revenue
-0.02
-
-0.02
2.08%
-0.02
0.75%
-0.01
18.87%
-0.01
17.14%
-0.01
0.85%
-0.01
8.60%
-0.01
5.22%
-0.01
4.88%
-0.01
1.97%
-0.01
0.18%
cash per share
3.43
-
2.17
36.89%
2.28
5.17%
3.22
41.46%
1.77
45.03%
6.30
255.82%
6.19
1.77%
8.29
33.91%
9.50
14.52%
11.98
26.20%
6.38
46.78%
days of inventory on hand
39.15
-
38.20
2.43%
40.31
5.54%
36.24
10.11%
35.74
1.38%
36.83
3.05%
30.26
17.82%
30.73
1.55%
27.00
12.14%
25.98
3.78%
11.72
54.87%
days payables outstanding
19.66
-
20.96
6.60%
21.57
2.89%
19.51
9.54%
20.71
6.15%
19.98
3.51%
18.13
9.27%
18.51
2.09%
19.07
3.05%
20.20
5.89%
9.69
52.02%
days sales outstanding
25.13
-
25.37
0.94%
28.31
11.57%
25.01
11.65%
26.04
4.12%
33.07
27.01%
27.89
15.69%
29.53
5.91%
30.53
3.36%
30.87
1.14%
35.94
16.40%
debt to assets
0.19
-
0.17
6.88%
0.29
68.07%
0.29
0.61%
0.28
2.61%
0.37
31.68%
0.40
7.05%
0.37
7.87%
0.33
11.51%
0.31
5.00%
0.30
3.24%
debt to equity
0.35
-
0.34
3.39%
0.74
116.34%
0.75
1.24%
0.72
4.16%
1.26
76.04%
1.39
10.51%
1.23
12.06%
1.01
17.40%
1.00
1.61%
0.98
1.69%
dividend yield
0.01
-
0.01
8.54%
0.01
25.17%
0.02
50.72%
0.03
27.50%
0.03
7.53%
0.03
9.61%
0.03
8.98%
0.02
34.27%
0.02
23.24%
0.03
29.83%
earnings yield
0.05
-
0.04
21.22%
0.05
15.36%
0.06
31.07%
0.09
42.60%
-0.01
109.70%
0.07
890.42%
0.08
16.99%
0.06
27.60%
0.04
39.35%
0.08
133.23%
enterprise value
96.41B
-
122.29B
26.84%
134.31B
9.83%
108.83B
18.97%
99.26B
8.80%
137.77B
38.81%
179.97B
30.63%
166.59B
7.43%
202.66B
21.65%
180.05B
11.16%
168.14B
6.62%
enterprise value over ebitda
9.73
-
11.38
16.95%
11.63
2.21%
8.09
30.47%
8.27
2.30%
10.69
29.16%
10.92
2.18%
8.98
17.79%
10.30
14.74%
8.78
14.72%
12.23
39.28%
ev to operating cash flow
16.67
-
15.03
9.86%
15.97
6.24%
10.81
32.31%
12.40
14.69%
15.54
25.37%
14.01
9.87%
10.50
25.04%
11.10
5.66%
11.13
0.31%
12.52
12.52%
ev to sales
0.76
-
0.88
15.37%
0.88
0.14%
0.61
30.03%
0.54
12.37%
0.71
31.80%
0.70
1.01%
0.62
11.54%
0.69
11.90%
0.56
19.52%
0.47
15.83%
free cash flow per share
3.12
-
5.17
65.58%
5.41
4.61%
7.31
35.22%
5.97
18.35%
6.54
9.56%
7.99
22.12%
10.26
28.44%
11.94
16.37%
10.25
14.12%
8.09
21.09%
free cash flow yield
0.04
-
0.05
23.05%
0.06
3.05%
0.09
67.54%
0.08
11.13%
0.10
21.23%
0.11
7.70%
0.15
39.70%
0.12
22.96%
0.11
4.93%
0.10
6.87%
graham net net
-14.25
-
-17.69
24.18%
-33.98
92.04%
-35.10
3.31%
-37.35
6.39%
-105.25
181.81%
-97.43
7.44%
-95.19
2.29%
-89.38
6.11%
-84.78
5.14%
-100.75
18.83%
graham number
51.44
-
54.24
5.44%
59.22
9.16%
61.86
4.47%
73.47
18.76%
26.72
63.63%
75.05
180.86%
80.88
7.77%
87.64
8.36%
63.26
27.82%
93.24
47.39%
income quality
1.26
-
1.75
39.13%
1.61
8.36%
1.89
17.90%
1.21
36.14%
-14.87
1,330.32%
1.94
113.03%
2.21
13.85%
2.31
4.84%
3.88
67.95%
intangibles to total assets
0.50
-
0.51
1.26%
0.56
8.70%
0.55
1.28%
0.55
0.09%
0.59
7.11%
0.51
13.47%
0.48
5.44%
0.46
3.26%
0.45
2.88%
0.48
7.05%
interest coverage
15.55
-
14.31
7.96%
11.01
23.08%
9.59
12.86%
8.96
6.55%
1.54
82.87%
3.95
157.25%
4.79
21.16%
5.27
10.15%
7.11
34.81%
5.17
27.24%
interest debt per share
11.44
-
11.69
2.20%
25.33
116.75%
26.66
5.25%
27.51
3.19%
72.84
164.75%
70.74
2.88%
67.19
5.03%
59.52
11.42%
55.65
6.49%
60.33
8.41%
inventory turnover
9.32
-
9.56
2.49%
9.05
5.25%
10.07
11.25%
10.21
1.40%
9.91
2.96%
12.06
21.68%
11.88
1.53%
13.52
13.82%
14.05
3.93%
31.13
121.61%
invested capital
0.35
-
0.34
3.39%
0.74
116.34%
0.75
1.24%
0.72
4.16%
1.26
76.04%
1.39
10.51%
1.23
12.06%
1.01
17.40%
1.00
1.61%
0.98
1.69%
market cap
87.10B
-
111.82B
28.38%
109.31B
2.24%
84.67B
22.54%
73.95B
12.66%
68.40B
7.50%
96.65B
41.30%
89.40B
7.50%
136.07B
52.19%
122.27B
10.14%
101.46B
17.01%
net current asset value
-8.26B
-
-10.31B
24.72%
-26.08B
153.02%
-26.59B
1.96%
-26.21B
1.43%
-92.67B
253.61%
-107.98B
16.52%
-104.64B
3.09%
-97.61B
6.72%
-91.28B
6.49%
-105.23B
15.29%
net debt to ebitda
0.94
-
0.97
3.70%
2.17
122.17%
1.80
17.09%
2.11
17.49%
5.38
155.07%
5.06
6.05%
4.16
17.72%
3.38
18.63%
2.82
16.70%
4.85
72.10%
net income per share
3.77
-
4
6.01%
4.68
17.11%
4.96
5.79%
6.49
31.02%
-0.57
108.76%
5.10
996.22%
5.48
7.55%
6.00
9.35%
3.29
45.21%
6.49
97.62%
operating cash flow per share
4.75
-
7.01
47.49%
7.52
7.36%
9.38
24.72%
7.85
16.35%
8.49
8.17%
9.88
16.30%
12.12
22.73%
13.85
14.25%
12.33
10.96%
10.45
15.26%
payables turnover
18.56
-
17.41
6.19%
16.92
2.80%
18.71
10.55%
17.63
5.79%
18.27
3.64%
20.13
10.22%
19.72
2.05%
19.14
2.96%
18.07
5.56%
37.67
108.41%
receivables turnover
14.52
-
14.39
0.93%
12.89
10.37%
14.59
13.18%
14.02
3.95%
11.04
21.27%
13.09
18.60%
12.36
5.58%
11.96
3.25%
11.82
1.12%
10.16
14.09%
research and ddevelopement to revenue
return on tangible assets
0.13
-
0.13
1.32%
0.13
1.67%
0.12
0.92%
0.15
23.54%
-0.01
104.75%
0.06
928.15%
0.06
1.20%
0.06
5.92%
0.03
45.72%
0.06
87.78%
revenue per share
104.16
-
120.04
15.25%
137.11
14.22%
165.45
20.67%
181.14
9.49%
186.38
2.89%
197.37
5.90%
205.28
4.01%
221.46
7.89%
245.78
10.98%
278.42
13.28%
roe
0.12
-
0.12
1.08%
0.14
15.08%
0.14
2.54%
0.18
21.70%
-0.01
105.81%
0.10
1,118.22%
0.10
0.40%
0.11
1.84%
0.06
42.38%
0.11
79.77%
roic
0.10
-
0.10
9.30%
0.09
15.11%
0.10
11.48%
0.12
19.25%
-0.01
110.97%
0.05
493.56%
0.06
15.10%
0.06
0.23%
0.08
28.28%
0.06
18.07%
sales general and administrative to revenue
shareholders equity per share
31.17
-
32.69
4.88%
33.27
1.76%
34.32
3.17%
36.95
7.66%
55.77
50.93%
49.09
11.98%
53.01
7.99%
56.92
7.37%
54.13
4.90%
59.50
9.93%
stock based compensation to revenue
0.00
-
0.00
6.44%
0.00
26.73%
0.00
16.66%
0.00
1.28%
0.00
13.62%
0.00
22.60%
0.00
15.62%
0.00
11.31%
0.00
16.34%
tangible asset value
1.87B
-
47M
97.48%
-14.78B
31,548.94%
-14.93B
0.98%
-14.39B
3.62%
-56.66B
293.85%
-48.70B
14.05%
-40.99B
15.83%
-32.77B
20.07%
-31.59B
3.59%
-43.87B
38.88%
tangible book value per share
1.53
-
0.04
97.36%
-13.22
32,758.51%
-13.91
5.22%
-14.10
1.39%
-54.27
284.79%
-37.43
31.03%
-31.32
16.34%
-24.84
20.68%
-24.08
3.08%
-34.14
41.80%
working capital
9.90B
-
6.96B
29.74%
7.21B
3.64%
4.79B
33.53%
581M
87.88%
1.23B
112.39%
-3.00B
343.19%
-5.65B
88.20%
-7.80B
38.08%
-4.05B
48.02%
-11.33B
179.50%

All numbers in (except ratios and percentages)